<SEC-DOCUMENT>0001169245-23-000054-index.html : 20231115 <SEC-HEADER>0001169245-23-000054.hdr.sgml : 20231115 <ACCEPTANCE-DATETIME>20231115161716 ACCESSION NUMBER: 0001169245-23-000054 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231115 EFFECTIVENESS DATE: 20231115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 231410807 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 </SEC-HEADER> <DOCUMENT> <TYPE>NT 10-Q <SEQUENCE>1 <FILENAME>phasebio-nt10xqq32023.htm <DESCRIPTION>NT 10-Q <TEXT> Document 1 - file: phasebio-nt10xqq32023.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>phasebio-nt10xqq32023001.jpg <TEXT> Document 2 - file: phasebio-nt10xqq32023001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>phasebio-nt10xqq32023002.jpg <TEXT> Document 3 - file: phasebio-nt10xqq32023002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>phasebio-nt10xqq32023003.jpg <TEXT> Document 4 - file: phasebio-nt10xqq32023003.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>phasebio-nt10xqq32023004.jpg <TEXT> Document 5 - file: phasebio-nt10xqq32023004.jpg
</DOCUMENT> </SEC-DOCUMENT>